thiram
Small moleculeexperimental
Clinical trial activity
3 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Dec 1, 1999 (NCT00001951)
Timeline
1990s
- Jan 1, 1999
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- granuflo
- granuflo
- rhenogran
- tetramethylthioperoxydicarbonic diamide
- tetramethylthiuram bisulfide
- tetramethylthiuram disulfide
- tetramethylthiuram disulphide
- thioscabin
- thiram
- thiram
- thiram
- thiram
- thiuram
- thiuramin
- thiuramyl
- thylate
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02334267 | N/A | Nov 1, 2014 | Fresenius, New Orleans Center for Clinical Research |
| NCT00013546 | Phase 2 | Mar 1, 2001 | National Institutes of Health (NIH) |
| NCT00001951 | Phase 2 | Dec 1, 1999 | National Institutes of Health (NIH) |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| National Institutes of Health (NIH) | Government | 2 | 2 | 1 | 1999 |
| Fresenius | For profit | 1 | 1 | 1 | 2014 |
| New Orleans Center for Clinical Research | For profit | 1 | 0 | 1 | 2014 |
3 organizations
Page 1 / 1